Collection 報告 [0/1] 專利 [0/82] 期刊論文 [110/110] 會議論文/會議摘要 [10/19] Siblings 伍素瑩 [52/65] 其他 [58/60] 夏克山 [76/98] 岳嶽 [29/32] 張仲明 [7/9] 張俊彥 [18/18] 張竣評 [21/26] 徐祖安 [170/215] 李秀珠 [75/105] 李靜琪 [23/24] 林書玉 [19/20] 洪明秀 [31/40] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [35/39] 童俊維 [23/23] 紀雅惠 [21/25] 翁紹華 [22/24] 莊宏 [1/1] 葉修華 [24/25] 葉燈光 [133/152] 蔣維棠 [41/66] 謝興邦 [171/231] 郭靜娟 [49/55] 鄒倫 [28/29] 陳志豪 [31/52] 陳新(2002-2015) [53/67] 陳炯東 [180/212] 顏婉菁 [6/7] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Community Statistics 近3年內發表的文件:1(0.47%) 含全文筆數:120(56.60%) 文件下載次數統計 下載大於0次:120(100.00%) 下載大於100次:120(100.00%) 檔案下載總次數:99105(1.85%) 最後更新時間: 2024-12-01 03:21 Top Upload Loading... Top Download Loading... Recent Submissions Selective and antagonist-dependent ... DBPR108, a novel dipeptidyl peptida... BPRDP056, a novel small molecule dr... BPRDP056, a novel small molecule dr... The in vivo antinociceptive and mu-... A novel, potent, and orally bioavai... 4-Bromophenylhydrazinyl benzenesulf... Identification of an oxime-containi... Targeting coronaviral replication a... A potent, selective, and orally bio...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 51-100 of 212. (5 Page(s) Totally) << < 1 2 3 4 5 > >> View [10|25|50] records per page

Date	Title	Relation
2013-11-21	治療癌症的醫藥組成物	I415852/2013-11-21
2013-11-13	Discovery of 1-(2,4-Dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5 -(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide as a novel peripherally restricted cannabinoid-1 receptor antagonist with significant weight-loss efficacy in diet-induced obese mice	Journal of Medicinal Chemistry. 2013 Nov 13;56(24):9920-9933.
2013-11	BPR0C305, an orally active microtubule-disrupting anticancer agent	Anticancer Drugs. 2013 Nov;24(10):1047-1057.
2013-10-01	喹啉化合物及包含其之治療病毒感染之醫藥組成物	I410245/2013-10-01
2013-09-27	Pyrrolidine derivatives	RU2494094C2/2013-09-27
2013-09-11	噻吩化合物及其醫藥組成物	I408136/2013-09-11
2013-08-21	Fused multicyclic compounds as protein kinase inhibitors	EP2331530B1/2013-08-21
2013-08-13	Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors	US8507502B2/2013-08-13
2013-07-16	Dibenzo[f,h]isoquinoline derivatives	US8486959B2/2013-07-16
2013-07-01	做為蛋白質激酶抑制劑之稠合多環化合物	I400242/2013-07-01
2013-06-28	Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine aurora kinase inhibitor	Journal of Medicinal Chemistry. 2013 Jun 28;56(13):5247-5260.
2013-06-05	Anticancer oral formulation	EP2310363B1/2013-06-05
2013-06	c-Jun-mediated anti-cancer mechanisms of tylophorine	Carcinogenesis. 2013 Jun;34(6):1304-1314.
2013-06	Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry. 2013 Jun;21(11):2856-2867.
2013-05	Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus	Antiviral Research. 2013 May;98(2):228-241.
2013-05	Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	Proceedings of the National Academy of Sciences of the United States of America. 2013 May;110(19):E1779-E1787.
2013-05	Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: The role of the DFG motif in the design of epidermal growth factor receptor inhibitors	Journal of Medicinal Chemistry. 2013 May;56(10):3889-3903.
2013-04-30	Pyrrolidine derivatives	164613/2013-04-30
2013-04-13	Exploration of the role of tylophorine E ring in anti-Coronavirus activity-Tylophorine derived dibenzoquinolines impart multi-biological activities as orally active agents	FASEB Journal. 2013 Apr 13;27:lb71.
2013-04-09	Proline derivatives	US8415482B2/2013-04-09
2013-04-07	BPR000K, a novel Aurora kinase inhibitor	Abstracts of Papers - American Chemical Society. 2013 Apr 7;245:Article number 300-MEDI.
2013-04-07	3D-QSAR assisted drug design: Identification of a potent quinazoline based Aurora kinase inhibitor	Abstracts of Papers - American Chemical Society. 2013 Apr 7;245:Article number 87-MEDI.
2013-04-07	Development drug candidate targeting EGFR kinase: DBPR112	Abstracts of Papers - American Chemical Society. 2013 Apr 7;245:Article number 299-MEDI.
2013-04	Tylophorine induces c-Jun protein accumulation through two discrete prolonged pathways NF-kappaB/PKCdelta/JNK and PI3K/PDK1/PP2A/eEF2 to promote G1 arrest in carcinoma cells	FASEB Journal. 2013 Apr;27:lb74.
2013-04	Identification of a quinone compound inhibits human glutaminase activity and induces autophagy in carcinoma cells	FASEB Journal. 2013 Apr;27:lb70.
2013-04	Design and synthesis of Aurora kinase inhibitors as anticancer agents	Abstracts of Papers - American Chemical Society. 2013 Apr;245:Article number 301-MEDI.
2013-03-27	Thiophene compounds	EP2068870/2013-03-27
2013-02-11	吡咯啉啶化合物	I385163/2013-02-11
2013-02-11	抗癌口服藥學組成物	I384984/2013-02-11
2013-02-11	作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物	I385174/2013-02-11
2013-02	Resistance studies of a di-thiazol analogue, DBPR110, as a potential hepatitis C virus NS5A inhibitor in replicon systems	Antimicrobial Agents and Chemotherapy. 2013 Feb; 57(2):723-733.
2013-01-15	Imidazol-4-one and imidazole-4-thione compounds	US8354442B2/2013-01-15
2013-01	3D-QSAR-assisted drug design: Identification of a potent quinazoline-based aurora kinase inhibitor	ChemMedChem. 2013 Jan;8(1):136-148.
2012-12-13	Synthesis and biological evaluation of tylophorine-derived dibenzoquinolines as orally active agents: Exploration of the role of tylophorine e ring on biological activity	Journal of Medicinal Chemistry. 2012 Dec 13;55(23):10363-10377.
2012-12	An efficient, mild and scalable synthesis of bioactive compounds containing the angelicin scaffold	Journal of the Chinese Chemical Society. 2012 Dec;59(12):1548-1554.
2012-11	BPR1J271, a novel FLT3 inhibitor for treating acute myeloid leukemia	European Journal of Cancer. 2012 Nov;48(Suppl. 6):53-54.
2012-09	Anti-influenza drug discovery: Identification of an orally bioavailable quinoline derivative through activity- and property-guided lead optimization	ChemMedChem. 2012 Sep;7(9):1546-1550.
2012-09	Putative tumor metastasis-associated genes in human gastric cancer	International Journal of Oncology. 2012 Sep;41(3):1068-1084.
2012-07-04	噻吩化合物	ZL200780036897.1/2012-07-04
2012-07	Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors	International Journal of Obesity. 2012 Jul;36(7):999-1006.
2012-06-15	Pyrrolidine derivatives	587911/2012-06-15
2012-06-12	Treatment of neurodegenerative disorders with thiourea compounds	US8198284B2/2012-06-12
2012-06-07	3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry Letters. 2012 Jun 7;22(14):4654-4659.
2012-06	EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells	Molecular Oncology. 2012 Jun;6(3):299-310.
2012-05-11	作為極光激酶抑制劑之稠合雙環嘧啶化合物	I363627/2012-05-11
2012-04-21	吡咯啉啶化合物	I362388/2012-04-21
2012-04-11	咪唑啉酮及咪唑啉硫酮衍生物	I361808/2012-04-11
2012-03-25	Design, synthesis, and SAR studies of duel FLT-3 and Aurora kinase inhibitors	Abstracts of Papers - American Chemical Society. 2012 Mar 25;243:Article number 48-MEDI.
2012-03-20	Fused bicyclic pyrimidine compounds as aurora kinase inhibitors	US8138194B2/2012-03-20
2012-03-01	C型肝炎病毒抑制劑	I359137/2012-03-01

Showing items 51-100 of 212. (5 Page(s) Totally) << < 1 2 3 4 5 > >> View [10|25|50] records per page